89Zr, a Radiometal Nuclide with High Potential for Molecular Imaging with PET: Chemistry, Applications and Remaining Challenges
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
89Zr, a Radiometal Nuclide with High Potential for Molecular Imaging with PET: Chemistry, Applications and Remaining Challenges
Authors
Keywords
-
Journal
MOLECULES
Volume 18, Issue 6, Pages 6469-6490
Publisher
MDPI AG
Online
2013-06-04
DOI
10.3390/molecules18066469
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intraoperative Imaging of Positron Emission Tomographic Radiotracers Using Cerenkov Luminescence Emissions
- (2018) Jason P. Holland et al. Molecular Imaging
- 89Zr-PET Radiochemistry in the Development and Application of Therapeutic Monoclonal Antibodies and Other Biologicals
- (2013) Danielle J. Vugts et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Pilot Study on the Feasibility of PET/CT Lymphoscintigraphy with 89Zr-Nanocolloidal Albumin for Sentinel Node Identification in Oral Cancer Patients
- (2013) D. A. Heuveling et al. JOURNAL OF NUCLEAR MEDICINE
- Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas
- (2013) Sibaprasad Bhattacharyya et al. NUCLEAR MEDICINE AND BIOLOGY
- Development of a Novel Long-Lived ImmunoPET Tracer for Monitoring Lymphoma Therapy in a Humanized Transgenic Mouse Model
- (2012) Arutselvan Natarajan et al. BIOCONJUGATE CHEMISTRY
- Investigation of Zr(iv) and89Zr(iv) complexation with hydroxamates: progress towards designing a better chelator than desferrioxamine B for immuno-PET imaging
- (2012) François Guérard et al. CHEMICAL COMMUNICATIONS
- Measurement of Tumor VEGF-A Levels with 89Zr-Bevacizumab PET as an Early Biomarker for the Antiangiogenic Effect of Everolimus Treatment in an Ovarian Cancer Xenograft Model
- (2012) A. R. M. van der Bilt et al. CLINICAL CANCER RESEARCH
- Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin’s lymphoma using 89Zr-ibritumomab tiuxetan and PET
- (2012) Saiyada N. F. Rizvi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Cyclotron production of 89Zr: A potent radionuclide for positron emission tomography
- (2012) M. Taghilo International Journal of Physical Sciences
- Immuno-PET of the Hepatocyte Growth Factor Receptor Met Using the 1-Armed Antibody Onartuzumab
- (2012) E. M. Jagoda et al. JOURNAL OF NUCLEAR MEDICINE
- Imaging Tumor Burden in the Brain with 89Zr-Transferrin
- (2012) M. J. Evans et al. JOURNAL OF NUCLEAR MEDICINE
- PET and MRI of Metastatic Peritoneal and Pulmonary Colorectal Cancer in Mice with Human Epidermal Growth Factor Receptor 1-Targeted 89Zr-Labeled Panitumumab
- (2012) T. K. Nayak et al. JOURNAL OF NUCLEAR MEDICINE
- Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy
- (2012) M. J. W. D. Vosjan et al. MOLECULAR CANCER THERAPEUTICS
- Lapatinib and 17AAG Reduce 89Zr-Trastuzumab-F(ab′)2 Uptake in SKBR3 Tumor Xenografts
- (2012) Thijs H. Oude Munnink et al. MOLECULAR PHARMACEUTICS
- Multimodality Imaging of Breast Cancer Experimental Lung Metastasis with Bioluminescence and a Monoclonal Antibody Dual-Labeled with 89Zr and IRDye 800CW
- (2012) Hao Hong et al. MOLECULAR PHARMACEUTICS
- Annotating MYC status with 89Zr-transferrin imaging
- (2012) Jason P Holland et al. NATURE MEDICINE
- ImmunoPET imaging of phosphatidylserine in pro-apoptotic therapy treated tumor models
- (2012) Annie Ogasawara et al. NUCLEAR MEDICINE AND BIOLOGY
- PET imaging with 89Zr: From radiochemistry to the clinic
- (2012) Melissa A. Deri et al. NUCLEAR MEDICINE AND BIOLOGY
- 89Zr-Labeled Paramagnetic Octreotide-Liposomes for PET-MR Imaging of Cancer
- (2012) Diane S. Abou et al. PHARMACEUTICAL RESEARCH
- Imaging Androgen Receptor Signaling with a Radiotracer Targeting Free Prostate-Specific Antigen
- (2012) David Ulmert et al. Cancer Discovery
- Accelerator production of the positron emitter zirconium-89
- (2011) Mahdi Sadeghi et al. ANNALS OF NUCLEAR ENERGY
- Implementation of 89Zr production and in vivo imaging of B-cells in mice with 89Zr-labeled anti-B-cell antibodies by small animal PET/CT
- (2011) Martin Walther et al. APPLIED RADIATION AND ISOTOPES
- Modular Strategy for the Construction of Radiometalated Antibodies for Positron Emission Tomography Based on Inverse Electron Demand Diels–Alder Click Chemistry
- (2011) Brian M. Zeglis et al. BIOCONJUGATE CHEMISTRY
- 89Zr-Labeled Dextran Nanoparticles Allow in Vivo Macrophage Imaging
- (2011) Edmund J. Keliher et al. BIOCONJUGATE CHEMISTRY
- Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105
- (2011) Hao Hong et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Quantitative imaging of 124I and 86Y with PET
- (2011) Mark Lubberink et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Zirconium-89-Trastuzumab Positron Emission Tomography As a Tool to Solve a Clinical Dilemma in a Patient With Breast Cancer
- (2011) Sietske B.M. Gaykema et al. JOURNAL OF CLINICAL ONCOLOGY
- PET with the 89Zr-Labeled Transforming Growth Factor- Antibody Fresolimumab in Tumor Models
- (2011) T. H. Oude Munnink et al. JOURNAL OF NUCLEAR MEDICINE
- Imaging of Prostate Cancer with Immuno-PET and Immuno-SPECT Using a Radiolabeled Anti-EGP-1 Monoclonal Antibody
- (2011) C. M. van Rij et al. JOURNAL OF NUCLEAR MEDICINE
- Targeting the Internal Epitope of Prostate-Specific Membrane Antigen with 89Zr-7E11 Immuno-PET
- (2011) A. Ruggiero et al. JOURNAL OF NUCLEAR MEDICINE
- 89Zr-Nanocolloidal Albumin-Based PET/CT Lymphoscintigraphy for Sentinel Node Detection in Head and Neck Cancer: Preclinical Results
- (2011) D. A. Heuveling et al. JOURNAL OF NUCLEAR MEDICINE
- Intraoperative Near-Infrared Fluorescence Tumor Imaging with Vascular Endothelial Growth Factor and Human Epidermal Growth Factor Receptor 2 Targeting Antibodies
- (2011) A. G. T. Terwisscha van Scheltinga et al. JOURNAL OF NUCLEAR MEDICINE
- Magnitude of Enhanced Permeability and Retention Effect in Tumors with Different Phenotypes: 89Zr-Albumin as a Model System
- (2011) C. Heneweer et al. JOURNAL OF NUCLEAR MEDICINE
- 89Zr Radiochemistry for Positron Emission Tomography
- (2011) Gregory W. Severin et al. Medicinal Chemistry
- Chelating Agents and their Use in Radiopharmaceutical Sciences
- (2011) B. Wangler et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- In vivo biodistribution and accumulation of 89Zr in mice
- (2011) Diane S. Abou et al. NUCLEAR MEDICINE AND BIOLOGY
- Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets
- (2011) Ruth Cohen et al. EJNMMI Research
- Immuno-Positron Emission Tomography: Shedding Light on Clinical Antibody Therapy
- (2010) Guus A.M.S. van Dongen et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- VEGF-PET Imaging Is a Noninvasive Biomarker Showing Differential Changes in the Tumor during Sunitinib Treatment
- (2010) W. B. Nagengast et al. CANCER RESEARCH
- Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
- (2010) Thaddeus J. Wadas et al. CHEMICAL REVIEWS
- Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
- (2010) E C Dijkers et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Trastuzumab Pharmacokinetics Influenced by Extent Human Epidermal Growth Factor Receptor 2–Positive Tumor Load
- (2010) Thijs H. Oude Munnink et al. JOURNAL OF CLINICAL ONCOLOGY
- 89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo
- (2010) J. P. Holland et al. JOURNAL OF NUCLEAR MEDICINE
- ImmunoSPECT and ImmunoPET of IGF-1R Expression with the Radiolabeled Antibody R1507 in a Triple-Negative Breast Cancer Model
- (2010) S. Heskamp et al. JOURNAL OF NUCLEAR MEDICINE
- 89Zr-Bevacizumab PET of Early Antiangiogenic Tumor Response to Treatment with HSP90 Inhibitor NVP-AUY922
- (2010) W. B. Nagengast et al. JOURNAL OF NUCLEAR MEDICINE
- PET of Hypoxia with 89Zr-Labeled cG250-F(ab')2 in Head and Neck Tumors
- (2010) B. A. W. Hoeben et al. JOURNAL OF NUCLEAR MEDICINE
- Cerenkov Luminescence Imaging of Medical Isotopes
- (2010) A. Ruggiero et al. JOURNAL OF NUCLEAR MEDICINE
- MicroPET Imaging of Integrin αvβ3 Expressing Tumors Using 89Zr-RGD Peptides
- (2010) Orit Jacobson et al. MOLECULAR IMAGING AND BIOLOGY
- Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine
- (2010) Maria J W D Vosjan et al. Nature Protocols
- Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET
- (2010) Jeff N. Tinianow et al. NUCLEAR MEDICINE AND BIOLOGY
- Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using 89Zr-DFO-Trastuzumab
- (2010) Jason P. Holland et al. PLoS One
- Radioimmunoimaging with Longer-Lived Positron-Emitting Radionuclides: Potentials and Challenges
- (2009) Tapan K. Nayak et al. BIOCONJUGATE CHEMISTRY
- 89Zr-trastuzumab PET visualises HER2 downregulation by the HSP90 inhibitor NVP-AUY922 in a human tumour xenograft
- (2009) Thijs H. Oude Munnink et al. EUROPEAN JOURNAL OF CANCER
- p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging
- (2009) Lars R. Perk et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Radiation Dosimetry of 89Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients
- (2009) P. K.E. Borjesson et al. JOURNAL OF NUCLEAR MEDICINE
- Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging
- (2009) E. C.F. Dijkers et al. JOURNAL OF NUCLEAR MEDICINE
- Standardized methods for the production of high specific-activity zirconium-89
- (2009) Jason P. Holland et al. NUCLEAR MEDICINE AND BIOLOGY
- Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30
- (2008) Lars R. Perk et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Disparity Between In Vivo EGFR Expression and 89Zr-Labeled Cetuximab Uptake Assessed with PET
- (2008) H. J.W.L. Aerts et al. JOURNAL OF NUCLEAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More